November 20, 2018 (1:30 PM)

Pre-clinical mouse models and breast cancer organoids reveal clues to therapeutic resistance and disease progression

Kristina Havas

Metabolism, Epigenetics and Breast Cancer,
FIRC Institute for Molecular Oncology, IFOM Milan

from NervianoMS